Caliway Biopharmaceuticals (TWSE: 6919) today announced that it has completed the submission of an Investigational New Drug (IND) application to the U.S. FDA for a Phase 2 clinical study of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback